The triple-receptor mechanism may offer some advantages for weight maintenance at lower doses, as the glucagon receptor activitys effect on metabolic rate could provide additional buffer against regain, but this remains theoretical until dedicated maintenance studies are published
As both a bariatric surgeon and obesity medicine specialist (and a GLP-1 patient myself), Im deeply familiar with what these medications can do, how they differ, and why your providers guidance is so essential
Oral GLP-1 medications may cause similar side effects as GLP-1 injectables, such as nausea, vomiting and diarrhea
Hypoglycemia may occur if too much insulin is taken, insufficient food is eaten, or more glucose is burned off with activity
Combining oral and injectable tirzepatide: a bad idea Some people wonder about using both delivery methods, perhaps injecting on some days and using sublingual drops on others
Some insulin syringes come in 0.5 mL (50 unit) or 0.3 mL (30 unit) sizes